FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients continued on their baseline medications and whenever indicated additional antibiotics were used in the majority of patients to treat exacerbations.
Slovenian: Kadar je bilo indicirano, so pri večini bolnikov uporabili dodatne antibiotike za zdravljenje eksacerbacij.
English: A single sputum sample from a CF patient may contain multiple isolates of P. aeruginosa and each isolate may have a different level of in vitro susceptibility to aztreonam.
Slovenian: En sam vzorec izpljunka bolnika s CF lahko vsebuje več izolatov povzročitelja P. aeruginosa in vsak posamezni izolat lahko izkazuje različno raven in vitro občutljivosti na aztreonam.
English: One hour following a single dose of 75 mg inhaled aztreonam (at approximately peak plasma concentration), the mean plasma level in patients with CF was 0.59 µg/ml.
Slovenian: Eno uro po enem 75-mg odmerku inhaliranega aztreonama (približno pri najvišji koncentraciji v plazmi) je bila srednja raven v plazmi pri bolnikih s CF 0,59 µg/ml.
English: Step C: While continuing to hold the vial steady with one hand, use the other hand to slowly pull the blue cap in a counterclockwise direction.
Slovenian: Korak C: Medtem ko z eno roko še vedno trdno držite vialo, z drugo roko počasi vlecite modro zaporko v obratni smeri urnega kazalca.
English: The adverse reactions considered at least possibly related to treatment from clinical study and postmarketing experience are listed below by body system organ class and frequency.
Slovenian: Neželeni učinki, za katere se na podlagi kliničnih študij in izkušenj med trženjem meni, da obstaja vsaj možna povezanost z zdravljenjem, so navedeni spodaj glede na organske sisteme in pogostnost.
English: The vial is then gently swirled until contents have completely dissolved.
Slovenian: Vialo nežno obračajte, dokler se vsebina popolnoma ne raztopi.
English: In a Phase 2 open-label study (GS-US-205-0162), 105 paediatric patients aged 3 months to < 18 years (24 patients aged 3 months to < 2 years; 25 patients aged 2 to < 6 years; 56 patients aged 6 to < 18 years) with CF and documented initial/new onset P. aeruginosa infection/colonisation received Cayston 3 times a day for a single course of 28 days.
Slovenian: V odprti študiji faze 2 (GS-US-205-0162) je 105 pediatričnih bolnikov, starih od 3 mesece do < 18 let (24 bolnikov, starih od 3 mesece do < 2 leti; 25 bolnikov, starih od 2 do < 6 let; 56 bolnikov, starih 6 do < 18 let) s CF in dokumentirano novo/ponovljeno okužbo/kolonizacijo z bakterijo P. aeruginosa v enem 28-dnevnem ciklu prejemalo zdravilo Cayston 3-krat na dnevno.
English: What Cayston looks like and contents of the pack
Slovenian: Izgled zdravila Cayston in vsebina pakiranja
English: or inhaled antipseudomonal antibiotics (84 versus 121, p = 0.004) than TNStreated patients.
Slovenian: ali inhalacijskih antibiotikov proti bakterijam Pseudomonas (84 v primerjavi s 121, p = 0,004), kot v skupini, zdravljeni z RTN.
English: The Phase 2 and 3 placebo-controlled, registrational studies permitted comparison of plasma concentrations 1 hour post dose of Cayston by age (6 to 12 years, 13 to 17 years, and ≥ 18 years).
Slovenian: Registracijske, s placebom kontrolirane študije faze 2 in faze 3 so omogočile primerjavo koncentracij v plazmi 1 uro po odmerku zdravila Cayston glede na starost (6 do 12 let, 13 do 17 let in ≥ 18 let).
English: In the limited subgroup of patients who received inhaled tobramycin for less than 84 days in the previous 12 months (n = 40), lung function improvements at Day 28 and across three 28-day treatment courses were numerically smaller among aztreonam-treated patients than TNS-treated patients.
Slovenian: V omejeni podskupini bolnikov, ki so prejemali inhalirani tobramicin manj kot 84 dni v predhodnih 12 mesecih (n = 40), so bila izboljšanja pljučne funkcije 28. dan in v treh 28-dnevnih ciklih zdravljenja številčno manjša v skupini bolnikov, zdravljenih z aztreonamom, kot v skupini bolnikov, zdravljenih z RTN.
English: CP-AI-005 enrolled 246 adult (predominantly) and paediatric patients.
Slovenian: CP-AI-005 V študiji CP-AI-005 je sodelovalo 246 odraslih (v večini) in pediatričnih bolnikov.
English: Solvent: 1 ml low density polyethylene ampoule.
Slovenian: Vehikel: 1 ml ampula iz polietilena nizke gostote.
English: Aztreonam is known to be excreted renally and therefore administration of Cayston in patients with renal impairment (serum creatinine > 2 times upper limit of normal) should be undertaken with caution.
Slovenian: Znano je, da se aztreonam izloča preko ledvic, zato je treba pri bolnikih z okvarjenim delovanjem ledvic (kreatinin v serumu > 2-kratna zgornja meja normale) zdravilo Cayston uporabljati previdno.
English: Do not use this medicine if you notice that the package has been tampered with.
Slovenian: Ne uporabljajte tega zdravila, če opazite znake odpiranja embalaže.
English: However, decreased P. aeruginosa susceptibility was not predictive of clinical efficacy of Cayston during the study.
Slovenian: Vendar pa na podlagi zmanjšane občutljivosti na povzročitelja P. aeruginosa ni bilo mogoče napovedati klinične učinkovitosti zdravljenja z zdravilom Cayston v obdobju študije.
English: A total of 79 patients who completed a 28-day treatment course and who did not receive an additional antipseudomonal antibiotic during the treatment period were evaluable 6 months after the end of treatment; of these, 58.2% (n = 46) remained free of P. aeruginosa throughout this time period.
Slovenian: Skupaj 79 bolnikov, ki so končali 28-dnevni cikel zdravljenja, in ki niso prejemali dodatnih antipsevdomonskih antibiotikov v obdobju zdravljenja, je bilo 6 mesecev po koncu zdravljenja mogoče oceniti; med njimi jih bakterije P. aeruginosa ves čas tega obdobja ni imelo 58,2 % (n = 46).
English: The occurrence of rash may be indicative of an allergic reaction to aztreonam.
Slovenian: Pojav izpuščaja je lahko znak alergijske reakcije na aztreonam.
English: Aztreonam binds to penicillin-binding proteins of susceptible bacteria, which leads to inhibition of bacterial cell wall synthesis, followed by filamentation and cell lysis.
Slovenian: Aztreonam se veže na beljakovine občutljivih bakterij, ki vežejo penicilin, kar povzroča zaviranje sinteze bakterijskih celičnih sten, ki ji sledita filamentacija in razpad celic.
English: Solvent for Cayston Sodium Chloride 0.17%
Slovenian: vehikel za zdravilo Cayston natrijev klorid 0,17 %
English: A 104-week rat inhalation toxicology study to assess the carcinogenic potential of ascending doses of aztreonamdemonstrated no drug-related increase in malignant tumours.
Slovenian: V 104-tedenski študiji inhalacijske toksičnosti pri podganah za ocenitev kancerogenega potenciala naraščajočih odmerkov aztreonama niso opazili z zdravilom povezanega povečanja malignih tumorjev.
English: antipseudomonal antibiotics related to respiratory events compared to TNS-treated patients (p = 0.0025).
Slovenian: antibiotikov proti bakterijam Pseudomonas, povezanih z respiratornimi dogodki, v primerjavi z bolniki, zdravljenimi z RTN (p = 0,0025).
English: Press down and turn the cap clockwise as far as it will go (Figure 3b).
Slovenian: Pokrov za zdravilo pritisnite navzdol in ga obračajte v smeri urnega kazalca, dokler gre (slika 3b).
English: Paediatric patients had clinical improvements with aztreonamas determined by an increase in FEV1, improvement in CFQ-R respiratory symptoms scores and decline in P. aeruginosa sputum density.
Slovenian: Pri pediatričnih bolnikih so bila klinična izboljšanja z aztreonamom ugotovljena s povečanjem FEV1, izboljšanjem rezultatov respiratornih simptomov CFQ-R in zmanjšanjem gostote P. aeruginosa v izpljunku.
English: It's best to use Cayston immediately after you have made up the solution.
Slovenian: Najboljše je, da zdravilo Cayston uporabite takoj, ko ste pripravili raztopino.
English: Treatment-emergent persistent isolation (defined as absent at screening/baseline then present at 3 or more subsequent consecutive visits) of MSSA occurred in 6% of aztreonam-treated patients compared to 3% of TNS-treated patients.
Slovenian: Persistentna izolacija MSSA, ki se je pojavila ob zdravljenju (opredeljena kot odsotnost pri presejanju/izhodišču, nato pa prisotna pri 3 ali več naslednjih zaporednih obiskih), se je pojavila pri 6 % bolnikov, zdravljenih z aztreonamom, v primerjavi s 3 % bolnikov, zdravljenih z RTN.
English: Cayston contains the active substance aztreonam.
Slovenian: Zdravilo Cayston vsebuje učinkovino aztreonam.
English: Do not stop taking Cayston without first talking to your doctor.
Slovenian: Ne prenehajte jemati zdravila Cayston brez posveta z zdravnikom.
English: The known mechanism of resistance to aztreonam mediated by acquisition of genes involves acquisition of extended spectrum beta-lactam enzymes (ESBLs) that hydrolyse the fourmember, nitrogen-containing ring of aztreonam.
Slovenian: Znan mehanizem odpornosti na aztreonam, ki ga povzroči pridobivanje genov, zajema pridobivanje betalaktam encimov z razširjenim spektrom (ESBL - extended spectrum beta-lactam enzymes), ki hidrolizira štiričlanski obroč aztreonama, ki vsebuje dušik.
English: Do not completely tear through the metal seal.
Slovenian: Kovinskega tesnila ne smete v celoti pretrgati.
English: The use of Cayston in paediatric CF patients has been associated with haemoptysis during treatment cycles and could have aggravated underlying conditions.
Slovenian: Uporaba zdravila Cayston pri pediatričnih bolnikih s CF je bila v ciklih zdravljenja povezana s hemoptizo in je lahko poslabšala osnovne bolezni.
English: Safely dispose of the metal seal.
Slovenian: Varno odstranite kovinsko tesnilo.
English: Sodium chloride Water for injections
Slovenian: Vehikel natrijev klorid voda za injekcije
English: Gently tap the amber vial containing the Cayston so that the powder settles at the bottom.
Slovenian: Nežno potolcite po rjavi viali, ki vsebuje zdravilo Cayston, da se prašek usede na dnu.
English: Replacing the Altera Nebuliser Handset
Slovenian: Zamenjava pršilnika nebulatorja Altera
English: Next, gently swirl the vial until the powder has completely dissolved and the liquid is clear.
Slovenian: Nato nežno obračajte vialo, dokler se prašek povsem ne raztopi in ne dobite bistre tekočine.
English: Development of resistance during inhaled aztreonam therapy could limit treatment options during acute exacerbations.
Slovenian: Razvoj odpornosti med inhalacijsko terapijo z aztreonamom lahko omeji možnosti zdravljenja med akutnimi poslabšanji.
English: The in vitro antimicrobial susceptibility test methods used for parenteral aztreonam therapy can be used to monitor the susceptibility of P. aeruginosa isolated from CF patients.
Slovenian: Metode preskušanja antimikrobne občutljivosti in vitro, uporabljene za parenteralno terapijo z aztreonamom, se lahko uporabljajo za nadziranje občutljivosti povzročitelja P. aeruginosa, izoliranega iz bolnikov s CF.
English: Tabulated summary of adverse reactions
Slovenian: Tabelarični povzetek neželenih učinkov
English: Aztreonam is not extensively metabolised.
Slovenian: Aztreonam se ne presnavlja obsežno.
English: Non-clinical data for aztreonam for injection about fertility do not indicate any adverse effects.
Slovenian: Predklinični podatki o vplivu aztreonama za injiciranje na plodnost ne kažejo na neželene učinke.
English: Rash has been reported with the use of Cayston and may be indicative of an allergic reaction to aztreonam (see section 4.4).
Slovenian: Poročali so o izpuščaju, ki se je pojavil po uporabi zdravila Cayston, kar je lahko znak alergijske reakcije na aztreonam (glejte poglavje 4.4).
English: The liquid is squeezed out of one solvent ampoule into the glass vial.
Slovenian: Tekočino iz ene ampule z vehiklom iztisnite v stekleno vialo.
English: - The solvent ampoule contains water for injections and sodium chloride.
Slovenian: - Ampula z vehiklom vsebuje vodo za injekcije in natrijev klorid.
English: Preparing your Cayston for inhalation
Slovenian: Priprava zdravila Cayston za inhaliranje
English: In the two Phase 3 placebo-controlled clinical studies where patients received Cayston for 28 days, the most frequently occurring adverse reactions to Cayston were cough (58%), nasal congestion (18%), wheezing (15%), pharyngolaryngeal pain (13.0%), pyrexia (12%) and dyspnoea (10%).
Slovenian: V dveh s placebom kontroliranih kliničnih študijah faze 3, v katerih so bolniki zdravilo Cayston prejemali 28 dni, so bili najpogostejši neželeni učinki povezani z zdravilom Cayston kašelj (58%), zamašen nos (18%), sopenje (15%), faringolaringalna bolečina (13%), pireksija (12%) in dispneja
English: Bronchospasm
Slovenian: Bronhospazem
English: During the 6-month randomised phase of study GS-US-205-0110, treatment-emergent isolation of MSSA and MRSA was observed more commonly among aztreonam-treated patients than Tobramycin Nebuliser Solution (TNS)-treated patients.
Slovenian: Med 6-mesečno randomizirano fazo študije GS-US-205-0110, so izolacijo MSSA in MRSA, ki se je pojavila ob zdravljenju, pri bolnikih, zdravljenih z aztreonamom, opazili bolj pogosto kot pri bolnikih, zdravljenih z raztopino tobramicina za nebulator (RTN).
English: Since the plasma concentration of aztreonam following administration of Cayston (75 mg) is approximately 0.6 µg/ml, compared to serum levels of 54 µg/ml following administration of aztreonam for injection (500 mg), no safety issues associated with aztreonam overdose are anticipated.
Slovenian: Ker je koncentracija aztreonama v plazmi po uporabi zdravila Cayston (75 mg) približno 0,6 µg/ml v primerjavi z ravnjo v serumu 54 µg/ml po uporabi aztreonama za injiciranje (500 mg), ni za pričakovati težav z varnostjo, povezanih s prevelikim odmerjanjem aztreonama.
English: If you stop taking Cayston
Slovenian: Če ste prenehali uporabljati zdravilo Cayston
English: cough, nasal congestion, wheezing, pharyngolaryngeal pain, dyspnoea
Slovenian: kašelj, zamašen nos, sopenje, faringolaringalna bolečina, dispneja
English: An association between persistent isolation of MRSA and more severe disease and increased mortality has been reported in the literature.
Slovenian: V literaturi poročajo o povezavi med persistentno izolacijo MRSA in hujšo boleznijo in povečano smrtnostjo.
English: Treatment-emergent intermittent isolation of MRSA occurred in 7% of aztreonam-treated patients compared to 1% of TNS-treated patients and treatment-emergent persistent isolation of MRSA occurred in 3% of aztreonam-treated patients compared to no TNS-treated patients.
Slovenian: Prehodna izolacija MRSA, ki se je pojavila ob zdravljenju, se je pojavila pri 7 % bolnikov, zdravljenih z aztreonamom, v primerjavi z 1 % bolnikov, zdravljenih z RTN in persistentna izolacija MRSA, ki se je pojavila ob zdravljenju, se je pojavila pri 3 % bolnikov, zdravljenih z aztreonamom, v primerjavi z nič bolniki, zdravljenimi z RTN.
English: Pooled sputum concentration data from the Phase 2 and 3 registrational studies revealed some evidence of lower mean sputum concentrations in patients aged 13 to 17 years following one dose of Cayston 3 times a day.
Slovenian: Združeni podatki koncentracij v izpljunku iz registracijskih študij faze 2 in faze 3 so razkrili nekatere dokaze o nižjih srednjih koncentracijah v izpljunku pri bolnikih, starih 13 do 17 let, po enem odmerku zdravila Cayston 3-krat dnevno.
English: Cayston is indicated for use in paediatric patients aged 6 years and older with repeated cycles of 28 days on therapy followed by 28 days off Cayston therapy based on the above clinical experience.
Slovenian: Zdravilo Cayston je indicirano za uporabo pri pediatričnih bolnikih, starih 6 let in več, v ponavljajočih 28-dnevnih ciklih zdravljenja, ki jim sledi 28-dnevno obdobje brez jemanja zdravila Cayston, na podlagi zgoraj navedenih kliničnih izkušenj.
English: Studies were conducted using the Altera Nebuliser System to administer Cayston.
Slovenian: Študije so izvajali s sistemom nebulatorja Altera za dajanje zdravila Cayston.
English: Over nine 28-day courses of therapy, measures of pulmonary function (FEV1), CFQ-R respiratory symptoms scores, and P. aeruginosa sputum density showed a trend to improvement while the patients were on treatment compared with off treatment.
Slovenian: V devetih 28-dnevnih ciklih zdravljenja so meritve pljučne funkcije (FEV1), rezultatov respiratornih simptomov CFQ-R in gostote P. aeruginosa v izpljunku v času zdravljenja pokazali trend izboljšanja v primerjavi z rezultati v času, ko bolniki niso prejemali zdravila.
English: Patients should use a bronchodilator before each dose of Cayston.
Slovenian: Bolniki morajo pred vsakim odmerkom zdravila Cayston uporabiti bronhodilatator.
English: If you forget to take Cayston
Slovenian: Če ste pozabili uporabiti zdravilo Cayston
English: - Do not prepare Cayston until you are ready to administer a dose.
Slovenian: - Zdravila Cayston ne pripravite, če niste pripravljeni na uporabo odmerka.
English: The elimination half-life of aztreonam from serum is approximately 2.1 hours for inhalation administration, similar to what has been reported for aztreonam for injection.
Slovenian: Razpolovni čas izločanja aztreonama iz seruma je približno 2,1 ure za uporabo z inhaliranjem, kar je podobno kot izločanje aztreonama, uporabljenega z injiciranjem.
English: A total of 137 paediatric patients aged 6 to 17 years with chronic P. aeruginosa infection and FEV1 ≤ 75% predicted have received Cayston in Phase 2 and Phase 3 clinical studies.
Slovenian: Skupaj 137 pediatričnih bolnikov, starih 6 do 17 let, s kronično okužbo z bakterijo P. aeruginosa in z napovedanim odstotkom FEV1 ≤ 75 %, je prejelo zdravilo Cayston v kliničnih študijah faze 2 in faze 3.
English: May be stored outside a refrigerator but below 25°C for up to 28 days.
Slovenian: Lahko shranjujete zunaj hladilnika na temperaturi do 25 °C do 28 dni.
English: Using one hand to hold the vial steady, use the other hand to slowly flip up the blue cap.
Slovenian: Z eno roko trdno držite vialo, z drugo roko pa počasi privzdignite modro zaporko.
English: Aztreonam-treated patients also demonstrated larger mean improvements in CFQ-R respiratory symptoms scores compared to TNS-treated patients across 3 treatment courses (6.30 versus 2.17, p = 0.019).
Slovenian: Pri bolnikih, zdravljenih z aztreonamom, je bilo srednje izboljšanje rezultatov respiratornih simptomov CFQ-R v primerjavi z bolniki, zdravljenimi z RTN, v vseh 3 ciklih zdravljenja boljše (6,30 v primerjavi z 2,17, p = 0,019).
English: For inhalation use.
Slovenian: Za inhaliranje.
English: All patients were treated with Tobramycin Nebuliser Solution (TNS) 300 mg, 2 times a day in the four weeks immediately prior to receiving Cayston or placebo either 2 or 3 times a day for 28 days.
Slovenian: Vse bolnike so zdravili z raztopino tobramicina za nebulator (RTN) v odmerku 300 mg, 2-krat na dan, štiri tedne preden so prejemali zdravilo Cayston ali placebo 2-krat ali 3-krat na dan, 28 dni.
English: The development of antibiotic-resistant P. aeruginosa and superinfection with other pathogens represent potential risks associated with antibiotic therapy.
Slovenian: Razvoj proti antibiotikom odpornega povzročitelja P. aeruginosa in superinfekcij z drugimi patogeni predstavlja potencialna tveganja, povezana z zdravljenjem z antibiotiki.
English: Talk to your doctor before taking Cayston: - if you are allergic to any other antibiotics (such as penicillins, cephalosporins, and/or carbapenems) - if you do not tolerate or have chest tightness from taking other inhaled medicines
Slovenian: Pred začetkom uporabe zdravila Cayston se posvetujte z zdravnikom: - če ste alergični na druge antibiotike (kot so penicilini, cefalosporini in/ali karbapenemi) - če ne prenašate drugih zdravil za inhaliranje, ali če zaradi njih čutite stiskanje v prsnem košu - če imate težave z ledvicami - če ste kadar koli izkašljali kri - če ste kadar koli imeli nizke rezultate testa pljučne funkcije.
English: If not used immediately, the reconstituted solution must be stored at 2°C - 8°C and used within 8 hours.
Slovenian: Rekonstituirano raztopino, ki je ne porabite takoj, morate shranjevati v hladilniku na 2 °C − 8 °C in uporabiti v 8 urah.
English: Administration of Cayston in CF patients with active haemoptysis should be undertaken only if the benefits of treatment are considered to outweigh the risks of inducing further haemorrhage.
Slovenian: Zdravilo Cayston se sme bolnikom s CF z aktivno hemoptizo dajati le, če so koristi zdravljenja večje od tveganj za povzročitev nadaljnje krvavitve.
English: Pour all of the prepared Cayston from the vial into the Altera Nebuliser Handset medicine reservoir (Figure 3a).
Slovenian: Celotno količino pripravljenega zdravila Cayston vlijte iz viale v vsebnik za zdravilo kompleta z nebulatorjem Altera (slika 3a).
English: An increased prevalence of methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive S. aureus (MSSA), Aspergillus and Candida species was observed over time in patients treated with several Cayston treatment courses.
Slovenian: Čez čas so opazili povečano razširjenost vrst proti meticilinu odpornih Staphylococcus aureus (methicillin-resistant Staphylococcus aureus, MRSA), na meticilin občutljivih S. aureus (methicillinsensitive S. Aureus, MSSA), Aspergillus in Candida pri bolnikih, zdravljenih z zdravilom Cayston v več ciklih zdravljenja.
English: In the Phase 3 placebo-controlled studies of Cayston, local aztreonam concentrations generally exceeded aztreonam MIC values for P. aeruginosa, regardless of the level of P. aeruginosa susceptibility.
Slovenian: V s placebom kontroliranih študijah faze 3 zdravila Cayston so lokalne koncentracije aztreonama običajno presegle vrednosti MIK aztreonama za povzročitelja P. aeruginosa, neodvisno od stopnje občutljivosti povzročitelja P. aeruginosa.
English: If not used immediately, the prepared solution must be stored at 2°C - 8°C and used within 8 hours.
Slovenian: Pripravljeno raztopino, ki je ne porabite takoj, morate shranjevati v hladilniku na 2 °C - 8 °C in uporabiti v 8 urah.
English: What you need to know before you take Cayston Do not take Cayston
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Cayston Ne uporabljajte zdravila Cayston:
English: One plastic ampoule of solvent (0.17% w/v sodium chloride).
Slovenian: eno plastično ampulo vehikla (0,17% m/v natrijevega klorida).
English: Of the 101 patients, all having a positive cultures for P. aeruginosa within 30 days of study enrolment, of whom 56 (55.4%) were free of P. aeruginosa at baseline who completed a 28-day treatment course 89.1% (n = 90) were free of P. aeruginosa at the end of treatment (Day 28) and 75.2% (n = 76) were free of P. aeruginosa 1 month after the end of treatment (Day 56).
Slovenian: Med 101 bolnikom, ki so imeli vsi pozitivne kulture za bakterijo P. aeruginosa v 30 dneh po vključitvi v študijo, in med katerimi jih 56 (55,4 %) ob izhodišču ni imelo bakterije P. aeruginosa, ki so dokončali 28-dnevni cikel zdravljenja, jih ob koncu zdravljenja 89,1 % (n = 90) ni imelo bakterije P. aeruginosa (28. dan) in 75,2 % (n = 76) jih 1 mesec po koncu zdravljenja (56. dan) ni imelo bakterije P. aeruginosa.
English: Do not twist the blue cap.
Slovenian: Modre zaporke ne smete zvijati.
English: bronchospasm1, chest discomfort, rhinorrhoea, haemoptysis1 Skin and subcutaneous tissue disorders: Common:
Slovenian: bronhospazem1, bolečine v prsih, rinoreja, hemoptiza1 Bolezni kože in podkožja:
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CAYSTON INNER CARTON
Slovenian: PODATKI NA ZUNANJI OVOJNINI CAYSTON NOTRANJA ŠKATLA
English: Peak levels of aztreonam are achieved at about one hour after i.m.
Slovenian: Farmakokinetične lastnosti aztreonama za injiciranje Najvišje ravni aztreonama so dosežene približno eno uro po i.m.
English: It is recommended that Cayston be administered immediately after reconstitution with solvent.
Slovenian: Priporoča se, da se zdravilo Cayston uporabi takoj po rekonstituciji z vehiklom.
English: Do not reconstitute or mix Cayston with any other solvent or medicinal product.
Slovenian: Zdravila Cayston ne rekonstituirajte in ne mešajte z drugimi vehikli ali zdravili.